News & Publications
The latest news and publications about Merkel cell carcinoma and merkelcell.org.
Dear friends of Merkel cell carcinoma research, During this time of giving and celebrations, I want to let you know how appreciative our Merkel Team is of your support. This year was one of many exciting milestones that I am excited to share with you. We have created the new website that you ...
Read more →On December 7, 2016, GeekWire published an article highlighting the various advantages of the Merkel cell carcinoma antibody test. The test can be used to detect recurrence of MCC (in patients that produce antibodies) prior to catching a recurrence on a scan. Dr. Nghiem, the lead author of the ...
Read more →On December 7, 2016, Medical Xpress published an article highlighting the benefits that are associated with the Merkel cell carcinoma antibody test in light of the recently published paper, in the journal Cancer. The test works by measuring the presence of a novel marker - an antibody to a cancer-...
Read more →Mark Teich, executive editor of The Skin Cancer Foundation, spoke with Paul Nghiem, MD, PhD, about recent landmark progress in the detection, monitoring and treatment of patients with Merkel cell carcinoma (MCC). Q & A with Dr. Nghiem
Read more →7th Edition MCC Staging System Table Stage Primary Tumor Lymph Node Metastasis 0 In situ primary tumor No regional lymph node metastasis No distant metastasis IA Less than or equal to 2 cm maximum tumor dimension Nodes negative by pathologic exam No distant metastasis ...
Read more →As of January 2017, the AJCC 8th edition staging system will replace the 7th edition staging system. MCC patients will be categorized by their extent of disease at diagnosis (stage) as summarized in the 8th Edition table (see below) starting in 2017. The 2017 MCC staging system was based on an analy...
Read more →Natalie Miller, a University of Washington PhD candidate, successfully defended her thesis on June 1, 2016.
Read more →Dr. Nghiem was honored to speak about Merkel cell carcinoma at the the Sidney Kimmel Comprehensive Cancer Center's 2016 Director's Visiting Lecture Series on April 21 and April 22, 2016.
Read more →Dr. Nghiem was pleased and honored to be the keynote speaker at the 6th Annual Harley Haynes Lectureship and Symposium at Harvard Medical School on March 21, 2016. Dr. Haynes had an enormous influence on Dr. Nghiem’s career in terms of becoming a dermatologist and focusing on Merkel cell carcinoma...
Read more →The MMIG (Merkel cell carcinoma Multicenter Interest Group) had its annual meeting in Washington, DC, at the American Academy of Dermatology.
Read more →